{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,12,24]],"date-time":"2025-12-24T14:53:52Z","timestamp":1766588032215,"version":"3.44.0"},"reference-count":37,"publisher":"Elsevier BV","issue":"9","license":[{"start":{"date-parts":[[2006,3,1]],"date-time":"2006-03-01T00:00:00Z","timestamp":1141171200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2006,3,1]],"date-time":"2006-03-01T00:00:00Z","timestamp":1141171200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["DE015152","DE55304","DE014344"],"award-info":[{"award-number":["DE015152","DE55304","DE014344"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Molecular Immunology"],"published-print":{"date-parts":[[2006,3]]},"DOI":"10.1016\/j.molimm.2005.09.003","type":"journal-article","created":{"date-parts":[[2005,10,11]],"date-time":"2005-10-11T07:22:58Z","timestamp":1129015378000},"page":"1332-1339","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":32,"title":["Role of complement and B lymphocytes in Sj\u00f6gren's syndrome-like autoimmune exocrinopathy of NOD.B10-H2 mice"],"prefix":"10.1016","volume":"43","author":[{"given":"Cuong","family":"Nguyen","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Janet","family":"Cornelius","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Eric","family":"Singson","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Smruti","family":"Killedar","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Seunghee","family":"Cha","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ammon B.","family":"Peck","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.molimm.2005.09.003_bib1","doi-asserted-by":"crossref","first-page":"454","DOI":"10.1046\/j.1365-2249.1996.42748.x","article-title":"Circulating antibodies against rat parotid gland M3 muscarinic receptors in primary Sjogren's syndrome","volume":"104","author":"Bacman","year":"1996","journal-title":"Clin. Exp. Immunol."},{"key":"10.1016\/j.molimm.2005.09.003_bib2","doi-asserted-by":"crossref","first-page":"1574","DOI":"10.2337\/diab.42.11.1574","article-title":"Complement lytic activity has no role in the pathogenesis of autoimmune diabetes in NOD mice","volume":"42","author":"Baxter","year":"1993","journal-title":"Diabetes"},{"key":"10.1016\/j.molimm.2005.09.003_bib3","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1046\/j.1365-3083.2001.00958.x","article-title":"IL-4-dependent effector phase in autoimmune exocrinopathy as defined by the NOD.IL-4-gene knockout mouse model of Sjogren's syndrome","volume":"54","author":"Brayer","year":"2001","journal-title":"Scand. J. Immunol."},{"key":"10.1016\/j.molimm.2005.09.003_bib4","first-page":"353","article-title":"Sjogren's syndrome: immunological response underlying the disease","volume":"49","author":"Brayer","year":"2001","journal-title":"Arch. Immunol. Ther. Exp."},{"key":"10.1016\/j.molimm.2005.09.003_bib5","doi-asserted-by":"crossref","first-page":"545","DOI":"10.1146\/annurev.immunol.16.1.545","article-title":"The role of complement and complement receptors in induction and regulation of immunity","volume":"16","author":"Carroll","year":"1998","journal-title":"Annu. Rev. Immunol."},{"key":"10.1016\/j.molimm.2005.09.003_bib6","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1126\/science.1373518","article-title":"CD19: lowering the threshold for antigen receptor stimulation of B lymphocytes","volume":"256","author":"Carter","year":"1992","journal-title":"Science"},{"key":"10.1016\/j.molimm.2005.09.003_bib7","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1177\/154411130201300103","article-title":"Progress in understanding autoimmune exocrinopathy using the non-obese diabetic mouse: an update","volume":"13","author":"Cha","year":"2002","journal-title":"Crit. Rev. Oral Biol. Med."},{"key":"10.1016\/j.molimm.2005.09.003_bib8","doi-asserted-by":"crossref","first-page":"163","DOI":"10.4049\/jimmunol.167.1.163","article-title":"The role of the CD19\/CD21 complex in B cell processing and presentation of complement-tagged antigens","volume":"167","author":"Cherukuri","year":"2001","journal-title":"J. Immunol."},{"key":"10.1016\/j.molimm.2005.09.003_bib9","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1034\/j.1600-065X.2000.00618.x","article-title":"Follicular stromal cells and lymphocyte homing to follicles","volume":"176","author":"Cyster","year":"2000","journal-title":"Immunol. Rev."},{"key":"10.1016\/j.molimm.2005.09.003_bib10","doi-asserted-by":"crossref","first-page":"318","DOI":"10.1002\/art.1780400217","article-title":"Characterization of prelymphomatous stages of B cell lymphoproliferation in Sjogren's syndrome","volume":"40","author":"De Vita","year":"1997","journal-title":"Arthritis Rheum."},{"key":"10.1016\/j.molimm.2005.09.003_bib11","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1146\/annurev.immunol.21.120601.141021","article-title":"Location is everything: lipid rafts and immune cell signaling","volume":"21","author":"Dykstra","year":"2003","journal-title":"Annu. Rev. Immunol."},{"key":"10.1016\/j.molimm.2005.09.003_bib12","doi-asserted-by":"crossref","first-page":"393","DOI":"10.1146\/annurev.immunol.18.1.393","article-title":"Regulation of B lymphocyte responses to foreign and self-antigens by the CD19\/CD21 complex","volume":"18","author":"Fearon","year":"2000","journal-title":"Annu. Rev. Immunol."},{"key":"10.1016\/j.molimm.2005.09.003_bib13","doi-asserted-by":"crossref","first-page":"791","DOI":"10.1002\/art.1780230703","article-title":"Immune complexes in Sjogren's syndrome","volume":"23","author":"Fischbach","year":"1980","journal-title":"Arthritis Rheum."},{"key":"10.1016\/j.molimm.2005.09.003_bib14","doi-asserted-by":"crossref","first-page":"582","DOI":"10.1126\/science.280.5363.582","article-title":"Dependence of germinal center B cells on expression of CD21\/CD35 for survival","volume":"280","author":"Fischer","year":"1998","journal-title":"Science"},{"key":"10.1016\/j.molimm.2005.09.003_bib15","doi-asserted-by":"crossref","first-page":"517","DOI":"10.1016\/S0889-857X(21)00314-8","article-title":"Pathogenesis of Sjogren's syndrome","volume":"18","author":"Fox","year":"1992","journal-title":"Rheum. Dis. Clin. North Am."},{"key":"10.1016\/j.molimm.2005.09.003_bib16","first-page":"15","article-title":"Approaches to the treatment of Sjogren's syndrome","volume":"61","author":"Fox","year":"2000","journal-title":"J. Rheumatol. Suppl."},{"key":"10.1016\/j.molimm.2005.09.003_bib17","doi-asserted-by":"crossref","first-page":"741","DOI":"10.1002\/art.10221","article-title":"Long-term risk of mortality and lymphoproliferative disease and predictive classification of primary Sjogren's syndrome","volume":"46","author":"Ioannidis","year":"2002","journal-title":"Arthritis Rheum."},{"key":"10.1016\/j.molimm.2005.09.003_bib18","doi-asserted-by":"crossref","first-page":"644","DOI":"10.1038\/nrc1409","article-title":"MALT lymphoma: from morphology to molecules","volume":"4","author":"Isaacson","year":"2004","journal-title":"Nat. Rev. Cancer"},{"key":"10.1016\/j.molimm.2005.09.003_bib19","series-title":"Immunobiology","article-title":"The immune system in health and disease","author":"Janeway","year":"2001"},{"key":"10.1016\/j.molimm.2005.09.003_bib20","doi-asserted-by":"crossref","first-page":"927","DOI":"10.1016\/S0889-857X(05)70177-0","article-title":"Neuroendocrine manifestations in Sjogren's syndrome","volume":"26","author":"Johnson","year":"2000","journal-title":"Rheum. Dis. Clin. North Am."},{"key":"10.1016\/j.molimm.2005.09.003_bib21","series-title":"Arthritis and Allied Conditions\u2014A Textbook in Rheumatology","first-page":"1681","article-title":"Sj\u00f6gren's syndrome","author":"Jonsson","year":"2004"},{"key":"10.1016\/j.molimm.2005.09.003_bib22","doi-asserted-by":"crossref","first-page":"764","DOI":"10.1038\/ni0901-764","article-title":"Systemic lupus erythematosus: an autoimmune disease of B cell hyperactivity","volume":"2","author":"Lipsky","year":"2001","journal-title":"Nat. Immunol."},{"key":"10.1016\/j.molimm.2005.09.003_bib23","doi-asserted-by":"crossref","first-page":"1251","DOI":"10.1002\/art.1780281109","article-title":"Two types of inflammatory vascular disease in Sjogren's syndrome: differential association with seroreactivity to rheumatoid factor and antibodies to Ro (SS-A) and with hypocomplementemia","volume":"28","author":"Molina","year":"1985","journal-title":"Arthritis Rheum."},{"key":"10.1016\/j.molimm.2005.09.003_bib24","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1016\/S0161-5890(03)00111-1","article-title":"Complement therapeutics; history and current progress","volume":"40","author":"Morgan","year":"2003","journal-title":"Mol. Immunol."},{"key":"10.1016\/j.molimm.2005.09.003_bib25","doi-asserted-by":"crossref","first-page":"2297","DOI":"10.1002\/1529-0131(200010)43:10<2297::AID-ANR18>3.0.CO;2-X","article-title":"Evidence for antimuscarinic acetylcholine receptor antibody-mediated secretory dysfunction in nod mice","volume":"43","author":"Nguyen","year":"2000","journal-title":"Arthritis Rheum."},{"key":"10.1016\/j.molimm.2005.09.003_bib26","doi-asserted-by":"crossref","first-page":"739","DOI":"10.3109\/08830180109045588","article-title":"CD19, CD21, and CD22: multifaceted response regulators of B lymphocyte signal transduction","volume":"20","author":"Poe","year":"2001","journal-title":"Int. Rev. Immunol."},{"key":"10.1016\/j.molimm.2005.09.003_bib27","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1093\/rheumatology\/keh407","article-title":"Hypocomplementaemia as an immunological marker of morbidity and mortality in patients with primary Sjogren's syndrome","volume":"44","author":"Ramos-Casals","year":"2005","journal-title":"Rheumatology (Oxford)"},{"key":"10.1016\/j.molimm.2005.09.003_bib28","first-page":"G863","article-title":"PSP expression in murine lacrimal glands and function as a bacteria binding protein in exocrine secretions","volume":"272","author":"Robinson","year":"1997","journal-title":"Am. J. Physiol."},{"key":"10.1016\/j.molimm.2005.09.003_bib29","doi-asserted-by":"crossref","first-page":"7538","DOI":"10.1073\/pnas.95.13.7538","article-title":"Transfer of human serum IgG to non-obese diabetic Igmu null mice reveals a role for autoantibodies in the loss of secretory function of exocrine tissues in Sjogren's syndrome","volume":"95","author":"Robinson","year":"1998","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"key":"10.1016\/j.molimm.2005.09.003_bib30","doi-asserted-by":"crossref","first-page":"150","DOI":"10.1002\/1529-0131(199801)41:1<150::AID-ART18>3.0.CO;2-T","article-title":"A novel NOD-derived murine model of primary Sjogren's syndrome","volume":"41","author":"Robinson","year":"1998","journal-title":"Arthritis Rheum."},{"key":"10.1016\/j.molimm.2005.09.003_bib31","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1006\/clin.1996.0050","article-title":"Genetically programmed development of salivary gland abnormalities in the NOD (non-obese diabetic)-scid mouse in the absence of detectable lymphocytic infiltration: a potential trigger for sialoadenitis of NOD mice","volume":"79","author":"Robinson","year":"1996","journal-title":"Clin. Immunol. Immunopathol."},{"key":"10.1016\/j.molimm.2005.09.003_bib32","doi-asserted-by":"crossref","first-page":"1262","DOI":"10.1002\/art.20176","article-title":"Mortality and causes of death in primary Sjogren's syndrome: a prospective cohort study","volume":"50","author":"Theander","year":"2004","journal-title":"Arthritis Rheum."},{"key":"10.1016\/j.molimm.2005.09.003_bib33","doi-asserted-by":"crossref","first-page":"857","DOI":"10.1002\/art.1780290707","article-title":"Complement C3b receptors on erythrocytes, circulating immune complexes, and complement C3 split products in patients with primary Sjogren's syndrome","volume":"29","author":"Thomsen","year":"1986","journal-title":"Arthritis Rheum."},{"key":"10.1016\/j.molimm.2005.09.003_bib34","doi-asserted-by":"crossref","first-page":"554","DOI":"10.1136\/ard.61.6.554","article-title":"Classification criteria for Sjogren's syndrome: a revised version of the European criteria proposed by the American\u2013European Consensus Group","volume":"61","author":"Vitali","year":"2002","journal-title":"Ann. Rheum. Dis."},{"key":"10.1016\/j.molimm.2005.09.003_bib35","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1016\/j.molimm.2004.03.011","article-title":"Recombinant cobra venom factor","volume":"41","author":"Vogel","year":"2004","journal-title":"Mol. Immunol."},{"key":"10.1016\/j.molimm.2005.09.003_bib36","doi-asserted-by":"crossref","first-page":"1647","DOI":"10.1002\/1529-0131(200007)43:7<1647::AID-ANR31>3.0.CO;2-P","article-title":"Inhibitory effects of muscarinic receptor autoantibodies on parasympathetic neurotransmission in Sjogren's syndrome","volume":"43","author":"Waterman","year":"2000","journal-title":"Arthritis Rheum."},{"key":"10.1016\/j.molimm.2005.09.003_bib37","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1006\/clin.1996.0036","article-title":"Alterations in the secretory response of non-obese diabetic (NOD) mice to muscarinic receptor stimulation","volume":"78","author":"Yamamoto","year":"1996","journal-title":"Clin. Immunol. Immunopathol."}],"container-title":["Molecular Immunology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0161589005003317?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0161589005003317?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,27]],"date-time":"2025-09-27T13:21:55Z","timestamp":1758979315000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0161589005003317"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2006,3]]},"references-count":37,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2006,3]]}},"alternative-id":["S0161589005003317"],"URL":"https:\/\/doi.org\/10.1016\/j.molimm.2005.09.003","relation":{},"ISSN":["0161-5890"],"issn-type":[{"type":"print","value":"0161-5890"}],"subject":[],"published":{"date-parts":[[2006,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Role of complement and B lymphocytes in Sj\u00f6gren's syndrome-like autoimmune exocrinopathy of NOD.B10-H2b mice","name":"articletitle","label":"Article Title"},{"value":"Molecular Immunology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.molimm.2005.09.003","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2005 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}